Global, regional and national estimates of influenza-attributable ischemic heart disease mortality.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Chaves, Sandra SNealon, Joshua
Burkart, Katrin G
Modin, Daniel
Biering-Sørensen, Tor
Ortiz, Justin R
Vilchis-Tella, Victor M
Wallace, Lindsey E
Roth, Gregory
Mahe, Cedric
Brauer, Michael
Date
2022-11-18Journal
EClinicalMedicineType
Article
Metadata
Show full item recordAbstract
Background: Influenza virus infection is associated with incident ischemic heart disease (IHD) events. Here, we estimate the global, regional, and national IHD mortality burden attributable to influenza. Methods: We used vital registration data from deaths in adults ≥50 years (13.2 million IHD deaths as underlying cause) to assess the relationship between influenza activity and IHD mortality in a non-linear meta-regression framework from 2010 to 2019. This derived relationship was then used to estimate the global influenza attributable IHD mortality. We estimated the population attributable fraction (PAF) of influenza for IHD deaths based on the relative risk associated with a given level of weekly influenza test positivity rate and multiplied PAFs by IHD mortality from the Global Burden of Disease study. Findings: Influenza activity was associated with increased risk of IHD mortality across all countries analyzed. The mean PAF of influenza for IHD mortality was 3.9% (95% uncertainty interval [UI] 2.5-5.3%), ranging from <1% to 10%, depending on country and year. Globally, 299,858 IHD deaths (95% UI 191,216-406,809) in adults ≥50 years could be attributed to influenza, with the highest rates per 100,000 population in the Central Europe, Eastern Europe and Central Asia Region (32.3; 95% UI 20.6-43.8), and in the North Africa and Middle East Region (26.7; 95% UI 17-36.2). Interpretation: Influenza may contribute substantially to the burden of IHD. Our results suggest that if there were no influenza, an average of 4% of IHD deaths globally would not occur.Rights/Terms
© 2022 The Author(s).Identifier to cite or link to this item
http://hdl.handle.net/10713/20266ae974a485f413a2113503eed53cd6c53
10.1016/j.eclinm.2022.101740
Scopus Count
Collections
Related articles
- Estimating the cause-specific relative risks of non-optimal temperature on daily mortality: a two-part modelling approach applied to the Global Burden of Disease Study.
- Authors: Burkart KG, Brauer M, Aravkin AY, Godwin WW, Hay SI, He J, Iannucci VC, Larson SL, Lim SS, Liu J, Murray CJL, Zheng P, Zhou M, Stanaway JD
- Issue date: 2021 Aug 21
- Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.
- Authors: GBD 2019 LRI Collaborators
- Issue date: 2022 Nov
- Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
- Authors: GBD Chronic Kidney Disease Collaboration
- Issue date: 2020 Feb 29
- Global burden of ischemic heart disease attributable to ambient PM(2.5) pollution from 1990 to 2017.
- Authors: Wang L, Wu X, Du J, Cao W, Sun S
- Issue date: 2021 Jan
- Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.
- Authors: Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M
- Issue date: 2014 Apr 8